0
Skip to Content
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
DONATE
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
DONATE
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
Back
DONATE
  • Patient Videos & Webinars,
• 9/16/25

How Does a Genetic Mutation Lead to Cancer

How does a germline genetic mutation (also called a variant) like RUNX1-FPD lead to cancer? What role does a germline v. acquired (also callled somatic) mutation play in the process? Kayla Hamilton, MS, Certified Genetic Counselor, of Boston Children's Hospital and Dana-Farber Cancer Institute explains.

Previous

Hereditary Hematologic Malignancies: Not That Rare - Dr. Courtney DiNardo

Next

Hereditary Hematologic Malignancy Assessment: Making it Mainstream

You Might Also Like

Related Embedded Video Item Thumbnail RUNX1 Deficiency in Megakaryopoiesis: Discovering Therapeutics for RUNX1 Haploinsufficiency
Related Embedded Video Item Thumbnail Hereditary Hematologic Malignancies: Not That Rare - Dr. Courtney DiNardo
Related Embedded Video Item Thumbnail Module 4: Banking Stem Cells Today for the Possible Gene Editing Capabilities of Tomorrow
Related Embedded Video Item Thumbnail Hematopoietic stem cell division is governed by distinct RUNX1 binding partners
Related Embedded Video Item Thumbnail RRP Patient Meeting 2023: Scientific Conference Outcomes and Updates

Sign Up For Our Email List!

Enter your information below to receive the
latest RUNX1 news and updates!

Stay In Touch

Email RRP

Newsletter

Policies

Privacy Policy

Cookie Policy

Accessibility Statement

Site Resources

News & Updates

Calendar of Events

RRP Blog

DONATE
SHOP